Iraq: Rebuilding Cancer Care in a Fragile Health System – Capacity, Access, and Continuity in Post-Conflict Oncology

A Distinct Challenge in Middle Eastern Oncology

Iraq presents a particularly complex challenge in the Middle Eastern oncology landscape. Unlike Kuwait, Saudi Arabia, or Jordan, where healthcare infrastructure and institutional capacity are relatively advanced, Iraq’s health system is still emerging from decades of conflict, economic instability, and administrative fragmentation. In this context, early cancer detection is not just about raising awareness or promoting preventive behaviour; it fundamentally depends on the availability of functioning healthcare facilities, trained personnel, and equitable access across regions. Even highly motivated patients often encounter structural barriers that prevent timely diagnosis and treatment.

The Rising Burden of Cancer

Over the past few decades, Iraq has seen a steep rise in cancer incidence, although the country’s own registries likely underreport the full scale of the problem. In 2022 alone, 39,068 new cases were diagnosed among Iraqi nationals, with women affected more than men (58% versus 42%). Mortality remains high, with 11,421 deaths recorded and an age-standardised rate of 50.2 per 100,000. Breast cancer leads among women, while lung cancer remains the most common cause of death in men. Childhood cancers, particularly leukaemia and brain tumors, add a further dimension to the national health burden.

The long-term trends are stark. Cancer incidence has more than doubled since the late 1990s, with significant increases in breast, colorectal, and brain cancers. These numbers are more than statistics; they are the product of decades of wars, sanctions, and environmental hazards that have shaped the country’s health landscape.

War, Contamination, and Environmental Risk

Understanding Iraq’s cancer crisis requires looking beyond hospitals and clinics. For over forty years, military conflict and political instability have left a profound mark on both public health and health infrastructure. From the Iran-Iraq War (1980–1988) and the Gulf War (1990–1991), through UN sanctions, the 2003 US-led invasion, and the ISIS conflict (2014–2017), Iraq’s healthcare system has repeatedly been dismantled.

Depleted uranium (DU) munitions used during the Gulf Wars, chemical weapons, and industrial pollution have all contributed to a toxic environment. Studies in Basra show childhood leukemia rates doubling between 1993 and 2007, while overall cancer incidence in the province increased by 242% during the 1990s. Research in the Kurdistan Region links higher rates of kidney cancer among men to environmental exposure from both industrial and wartime sources. Although exact causal links are still debated, the combination of war, sanctions, and environmental toxins forms a unique risk landscape that complicates prevention and treatment.

Healthcare System Fragmentation and Infrastructure Gaps

Prior to the 1980s, Iraq had a promising oncology infrastructure, including oncology institutes in Baghdad and Mosul and several radiotherapy facilities. The government provided free, subsidized care, suggesting that Iraq could have been a regional leader in cancer treatment. However, decades of conflict, chronic underinvestment, and administrative neglect systematically eroded these gains.

Today, diagnostic and treatment capacity remains severely limited. Only around 15 linear accelerators function nationwide, while PET/CT access is restricted to a single machine. Pathology and molecular diagnostics are largely absent. These deficiencies mean that 50% to 80% of cancers are diagnosed at advanced stages, when even the best therapies offer limited hope. Hospitals often lack essential supplies and medications, and waiting times for radiotherapy can stretch for up to six months in some centres.

The fragmentation of the healthcare system exacerbates these challenges. Major urban centres such as Baghdad, Erbil, and Basra host the bulk of oncology services, while rural populations face long travel distances, financial constraints, and delays in referral. A severe brain drain of medical professionals over decades has further limited the country’s capacity to provide specialized care, with many oncologists and nurses leaving permanently.

Screening, Awareness, and Cultural Barriers

Iraq lacks a comprehensive national cancer screening program. Efforts have been made, particularly in breast cancer detection, but most initiatives cover only limited regions and fail to reach the population broadly. Awareness campaigns struggle against deeply embedded cancer stigma, cultural norms, and misinformation. Myths, such as cancer being contagious or divine punishment, exacerbate delays and reduce screening uptake. For many, cancer is associated with fear, shame, or social consequences, and women often face additional barriers related to modesty or reluctance to undergo examinations performed by male physicians.

Even where programs exist, structural gaps hinder effectiveness. Screening requires functioning clinics, diagnostic equipment, trained personnel, and follow-up care, all areas where Iraq remains constrained. As a result, early detection often depends more on luck than on systematic public health measures.

Signs of Recovery and International Support

Despite these challenges, there are important signs of rebuilding. International partnerships are helping strengthen Iraq’s oncology infrastructure. Programs with the International Atomic Energy Agency (IAEA) and the International Agency for Research on Cancer (IARC) support training, capacity building, and quality assurance in radiotherapy and nuclear medicine. Fellowships in Jordan and Turkey allow Iraqi clinicians to gain hands-on experience in advanced cancer centres.

At the domestic level, the Ministry of Health has opened 15 new hospitals and over 40 specialised centres, including cancer units, in recent years. Specialised treatments such as bone marrow transplantation have reported encouraging survival rates, and medical training programs are expanding at both national and regional levels. In the Kurdistan Region, the Hiwa Cancer Hospital has emerged as a regional hub, developed through international collaboration.

The Strategic Imperative

Iraq sits at a pivotal moment. Its young and growing population, combined with rising life expectancy and urbanisation, will inevitably increase cancer incidence. The country’s economy, heavily reliant on oil revenues, makes healthcare investment politically and financially discretionary. Yet the cost of inaction is clear: every patient forced to seek care abroad represents both a human and economic loss, highlighting the urgency of strengthening domestic capacity.

Early cancer detection in Iraq cannot be separated from system-wide recovery. Unlike Kuwait, Saudi Arabia, or Jordan, where the main barrier to early diagnosis is cultural or behavioural, Iraq’s challenge is structural: building the infrastructure, training personnel, ensuring equitable access, and establishing continuity of care. Only by addressing these foundational issues can early detection become feasible, accessible, and effective.

Iraq’s experience illustrates a fundamental principle for global oncology: early detection cannot succeed without a functioning health system. Investments in technology and training matter, but they must be coupled with stable infrastructure, equitable access, and sustainable health policy. As Iraq continues to rebuild, international collaboration, careful planning, and culturally sensitive awareness campaigns will be essential. By bridging the gap between capacity and access, Iraq can begin to transform its growing cancer burden into a manageable public health challenge, ensuring that more lives are saved in a country long defined by adversity.

For country-specific insights, explore the full series:

Kuwait: Modern Healthcare and the Challenge of Early Cancer Detection

Jordan: When Data Is Strong but Early Detection Still Lags

Saudi Arabia: National Transformation Meets the Challenge of Early Cancer Detection

For a broader regional perspective, see: Early Cancer Detection in the Middle East: Why Technology Alone Is Not Enough